ReviewRenal failure2025
The effect of thyroid disorders on the cutaneous manifestations in patients with chronic kidney disease.
Review in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For several decades, the cutaneous manifestations related to chronic kidney disease (CKD) have presented substantial clinical challenges. However, the underlying etiology and pathophysiology of these manifestations remain incompletely understood. Thyroid disorders represent a highly prevalent but often under-recognized endocrine dysfunction in patients with CKD. Recently, several studies have suggested that thyroid disorders play critical roles in modulating the cutaneous manifestations related to CKD and serve as a key factor in effectively addressing these issues. However, there is a notable lack of systematic reviews that comprehensively summarize the effect of thyroid disorders on CKD-related cutaneous manifestations, thereby impeding the advancement of research in this domain. In this review, we summarized the current knowledge on the effect of thyroid disorders on cutaneous manifestations related to CKD. Then, the underlying mechanisms through which thyroid disorders may induce or aggravate these cutaneous manifestations were further discussed. This comprehensive analysis can enhance our understanding on the roles of thyroid disorders in dermatological complications related to CKD, and help to identify novel targets and strategies for the effective management toward these refractory cutaneous manifestations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.